Form 4: Akoya Biosciences CFO John Frederick Ek Reports Stock Transaction
SEC Form 4 Filing
CFO of Akoya Biosciences, John Frederick Ek, reports disposition of shares to cover taxes on a restricted stock unit award.
Summary
- On March 1, 2025, John Frederick Ek, CFO of Akoya Biosciences, disposed of 3,594 shares of common stock to cover taxes related to a restricted stock unit award.
- The shares were disposed of at a price of $1.63 per share.
- Following the transaction, Ek directly owns 264,634 shares of Akoya Biosciences common stock.
- Ek also indirectly owns 20,000 shares through the Ek Trust Dated November 20, 2020.
Sentiment
Score: 5
Explanation: This is a neutral transaction related to tax obligations on vested stock, with no significant positive or negative implications.
Industry Context
This is a routine filing related to executive compensation and is common for publicly traded companies.
Key Dates
| Date | Description |
|---|---|
| 2020-11-20 | Date of Ek Trust |
| 2024-02-22 | Date of restricted stock unit award grant |
| 2025-03-01 | Date of stock transaction and first vesting date of restricted stock unit award |
| 2025-03-04 | Date of Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.